EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Efficacy and safety of moxibustion as a complementary and alternative therapy for asthma: A systematic review and meta-analysis

Guihua Deng, Xianjie Feng, Haifeng Zhang, Linhui Li, Qianan Cao, Yong Fu, Xu Zhou

International Immunopharmacology · 2024-09 · 139 · 112760

DOI: 10.1016/j.intimp.2024.112760 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Immunopharmacology, 2024-09. Verfasst von Guihua Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Acupuncture and Tuina, Jiangxi University of Chinese Medicine, Nanchang 330004, China. Hauptthemen laut MEDLINE: Moxibustion, Asthma, Quality of Life, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This systematic review of randomized controlled trials (RCTs) aimed to evaluate the efficacy and safety of moxibustion as a complementary or alternative treatment for asthma. METHODS: Seven databases were searched up to June 23, 2024, to identify RCTs assessing moxibustion for bronchial asthma. The outcomes of interest included response to treatment, asthma control, quality of life, lung function, immunological indicators, and incidence of adverse events (AEs). The treatment effects were measured by proportional odds ratios or mean differences with 95% confidence intervals. RESULTS: Thirty-seven RCTs (n = 2,879) were included. Moderate- to very low-quality evidence showed that compared with anti-asthmatic drugs alone, moxibustion plus anti-asthmatic drugs led to a significantly better response and greater increases in lung function, asthma control, and IgE levels. However, the combination therapy had no effect on children's quality of life. In the active comparisons, moxibustion resulted in a superior response to treatment and a greater improvement in asthma control and had comparable effects on lung function, quality of life, and IgE levels compared with anti-asthmatic drugs. The effects of moxibustion on the proportions of CD4 + and CD8 + T cells and the eosinophil count were inconsistent between the add-on and active comparisons. All reported AEs related to moxibustion were mild. CONCLUSIONS: Moxibustion, as an adjunctive treatment or used alone, may improve the response to treatment, lung function, asthma control, and IgE levels in patients with asthma with good safety. Its effects on children's quality of life and immune cell levels remain uncertain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MoxibustionAsthmaQuality of LifeRandomized Controlled Trials as TopicHumansTreatment OutcomeAnti-Asthmatic AgentsComplementary TherapiesImmunoglobulin ECombined Modality Therapy

Stichwörter der Autor:innen

AsthmaMeta-analysisMoxibustionSystematic reviewTraditional Chinese medicine

Substanzen

Anti-Asthmatic AgentsImmunoglobulin E

Autor:innen und Institutionen

  • College of Acupuncture and Tuina, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
  • Department of Acupuncture and Moxibustion, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China.
  • Department of Acupuncture and Moxibustion, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China. Electronic address: fuyong_acu@163.com.
  • Evidence-based Medicine Research Center, Jiangxi University of Chinese Medicine, Nanchang 330004, China; Key Laboratory of Drug-Targeting and Drug Delivery System of Sichuan Province, Chengdu 610041, China. Electronic a…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Deng, G., Feng, X., Zhang, H., Li, L., Cao, Q., Fu, Y., & Zhou, X. (2024). Efficacy and safety of moxibustion as a complementary and alternative therapy for asthma: A systematic review and meta-analysis. International Immunopharmacology, 139, 112760. https://doi.org/10.1016/j.intimp.2024.112760

Vancouver

Deng G, Feng X, Zhang H, Li L, Cao Q, Fu Y, et al. Efficacy and safety of moxibustion as a complementary and alternative therapy for asthma: A systematic review and meta-analysis. International Immunopharmacology. 2024;139:112760. doi:10.1016/j.intimp.2024.112760

BibTeX
@article{Deng2024,
  author = {Deng, Guihua and Feng, Xianjie and Zhang, Haifeng and Li, Linhui and Cao, Qianan and Fu, Yong and Zhou, Xu},
  title = {Efficacy and safety of moxibustion as a complementary and alternative therapy for asthma: A systematic review and meta-analysis},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {139},
  pages = {112760},
  doi = {10.1016/j.intimp.2024.112760}
}
Kostenlos starten →